Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2021-06-14 Board/Management Inform…
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
Bioera S.p.A. - Dimissioni di un consigliere di amministrazione
Board/Management Information Classification · 1% confidence The document is a formal announcement from Bioera S.p.A. regarding the resignation of a member of the Board of Directors ('Dimissioni di un consigliere di amministrazione'). The subject line explicitly states this ('Oggetto: Bioera S.p.A. - Dimissioni di un consigliere di amministrazione'). This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2021-06-14 Italian
Bioera S.p.A. - Richiesta di conversione Warrant A
Share Issue/Capital Change Classification · 1% confidence The document is an official regulatory filing ('Informazione Regolamentata n. 0771-49-2021') from an Italian company (Bioera S.p.A.) concerning a specific corporate action: the conversion of warrants into new ordinary shares and the issuance of new warrants (Warrant B). This action directly impacts the company's capital structure and share count. This falls under the category of financing activities or capital structure changes. The most appropriate classification among the provided options is 'Capital/Financing Update' (CAP), as it details the issuance of new shares resulting from a warrant conversion, which is a form of capital raising/restructuring. It is not a general earnings release (ER), an annual report (10-K), or a simple dividend notice (DIV). Since it is a detailed announcement of a capital event, it is more specific than a general Regulatory Filing (RNS).
2021-06-11 Italian
Relazione Amministratori Assemblea ordinaria azionisti 28-30 giugno 2021
AGM Information Classification · 1% confidence The document is titled "Relazione Illustrativa degli Amministratori sulle proposte concernenti le materie poste all'Ordine del Giorno dell'Assemblea" (Explanatory Report of the Directors on the proposals concerning the matters on the Agenda of the Assembly) for an "Assemblea Ordinaria" (Ordinary General Meeting) scheduled for June 28/30, 2021. The agenda items explicitly cover the approval of the 2020 financial statements, the allocation of the result of the financial year, and deliberation on the Remuneration Policy Report (Relazione sulla politica in materia di remunerazione). This document serves as the explanatory material provided to shareholders ahead of the meeting to inform their votes on these matters. This strongly aligns with the purpose of materials distributed for an Annual General Meeting (AGM). While it discusses the Annual Financial Statements (Item 1) and the Remuneration Report (Item 3), the document itself is the explanatory report *for* the meeting, making AGM-R the most appropriate classification over 10-K or DEF 14A, which are the underlying reports being discussed/voted upon. The structure and content are characteristic of pre-AGM documentation.
2021-06-07 Italian
Relazioni finanziarie annuali e relazioni di revisione annuali
Annual Report Classification · 1% confidence The document is titled 'Bilancio annuale 2020' (Annual Report 2020) for Bioera S.p.A. It contains a comprehensive 'Relazione degli Amministratori sulla gestione' (Management Report), consolidated financial statements, and detailed analysis of the company's performance, market trends, and financial position for the fiscal year 2020. As it is a full annual financial report, it is classified as a 10-K. FY 2020
2021-06-07 Italian
Bioera S.p.A. - Riemissione relazione società di revisione; pubblicazione relazione finanziaria 2020; pubblicazione documenti assemblea azionisti.
Report Publication Announcement Classification · 1% confidence The document is an official communication from Bioera S.p.A. dated June 7, 2021. The subject line and main headings explicitly state the 'Riemissione della relazione della società di revisione' (Reissuance of the auditor's report) for the 2020 annual financial statements, and the 'Pubblicazione della Relazione finanziaria annuale 2020' (Publication of the 2020 Annual Financial Report), along with documents for the upcoming shareholders' meeting. The text includes the full, reissued auditor's report which explicitly states an 'Dichiarazione di impossibilità di esprimere un giudizio' (Declaration of inability to express an opinion) regarding the 2020 financial statements. Since the document is announcing the publication of the Annual Financial Report (which is usually a 10-K equivalent in structure, but here is referred to as 'Relazione finanziaria annuale') and contains the detailed, reissued Audit Report, it covers elements of both the Annual Report (10-K) and the Audit Report (AR). However, the core focus of the announcement is the reissuance of the auditor's report due to issues with the underlying financial statements, and the document itself contains the full text of this specific audit report. Given the detailed inclusion of the auditor's findings and the reissuance notice, classifying it as an Audit Report/Information (AR) is highly appropriate, as it is a standalone report detailing audit results and accounting principles application (or lack thereof). Furthermore, it announces the publication of the Annual Financial Report, but the content provided is the audit opinion itself, making AR a stronger fit than 10-K (which would be the full financial filing) or RPA (which is just an announcement of publication).
2021-06-07 Italian
Bioera S.p.A. - Diffusione di informazioni ai sensi dell’art. 114, comma 5, del TUF
Legal Proceedings Report Classification · 1% confidence The document is a formal communication from Bioera S.p.A. dated June 4, 2021, titled 'Diffusione di informazioni ai sensi dell'art. 114, comma 5, del TUF' (Dissemination of information pursuant to art. 114, paragraph 5, of the TUF). This article in the Italian Consolidated Financial Act (TUF) mandates the disclosure of specific information when the auditor issues a qualified opinion or disclaimer on the financial statements. The text explicitly discusses the auditor's (RSM) inability to express an opinion on the 2020 financial statements regarding the going concern assumption and the valuation of goodwill ('Avviamento'). This is a mandatory disclosure responding to a regulatory request (Consob). Since it is a specific disclosure regarding audit findings and financial statement qualifications, it fits best under the 'Audit Report / Information' category (AR), rather than being the full Annual Report (10-K) or a general Regulatory Filing (RNS). The document length is substantial (over 55k characters), indicating it contains detailed information, not just a brief announcement of a report.
2021-06-04 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.